POC5 Inhibitors
Inhibition of the POC5 centriolar protein is a complex process that involves the disruption of various cellular mechanisms in which POC5 is directly implicated. Chemical compounds that disrupt microtubule dynamics, such as those that interfere with microtubule polymerization or stabilization, can indirectly inhibit the function of POC5. This is because POC5's role in centriole assembly and function is tightly coupled with the integrity of microtubule structures within the cell. Compounds that destabilize microtubules result in the improper localization and functioning of POC5, while those that abnormally stabilize microtubules can disrupt the dynamic behavior necessary for centriole function, where POC5 is localized. Other compounds exert their inhibitory effects by targeting cell cycle regulators and kinases directly involved in spindle assembly and centriole duplication-processes that are integral to POC5's role in the cell.
Furthermore, inhibitors targeting specific kinases such as PLK1 and Aurora kinases can indirectly lead to the inhibition of POC5 by preventing essential phosphorylation events needed for centriole maturation and function. The inhibition of these kinases results in the interruption of centriole replication cycles and spindle assembly, thereby impeding the role of POC5 in these processes. Additionally, the disruption of proteosomal and chaperone-mediated pathways that facilitate the folding and turnover of centriolar proteins can further inhibit POC5 function. Proteasome inhibitors that block the degradation of proteins may lead to the accumulation of misfolded proteins, including POC5, resulting in defective centriole assembly. Chaperone inhibitors, on the other hand, can prevent proper POC5 folding and complex formation, essential for its centriolar localization and function. Lastly, interventions that alter the post-translational modification landscape, such as SUMOylation or ubiquitination processes, could also affect POC5 stability and function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
A compound that disrupts microtubule polymerization, which is crucial for centriole assembly and function, a process POC5 centriolar protein is known to be involved in. This disruption can indirectly lead to the inhibition of POC5 by preventing its proper localization and function. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
A synthetic compound that interferes with the polymerization of microtubules, essential for centrosome function. As POC5 is important for centriole stability and spindle fiber attachment, this compound can indirectly inhibit POC5 by destabilizing the microtubules it associates with. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
A compound that stabilizes microtubules and as a result, can disrupt normal microtubule dynamics, which are crucial for centriole function where POC5 is localized. This stabilization indirectly inhibits POC5 functionality by inhibiting centriole dynamics and mitotic spindle formation. | ||||||
Monastrol | 254753-54-3 | sc-202710 sc-202710A | 1 mg 5 mg | $120.00 $233.00 | 10 | |
A kinesin Eg5 inhibitor that blocks centrosome separation, thereby indirectly affecting the role of POC5 in centriole duplication and spindle assembly. | ||||||
Purvalanol A | 212844-53-6 | sc-224244 sc-224244A | 1 mg 5 mg | $72.00 $297.00 | 4 | |
A CDK inhibitor that can halt cell cycle progression, which is necessary for centriole duplication where POC5 plays a role. Inhibition of CDKs could thereby indirectly inhibit POC5 activity as the centriole duplication process is disrupted. | ||||||
BI 2536 | 755038-02-9 | sc-364431 sc-364431A | 5 mg 50 mg | $151.00 $525.00 | 8 | |
A PLK1 inhibitor that can prevent centriole maturation and centrosome separation. POC5 is involved in the centriole replication cycle and PLK1 activity is essential for this process, thus this compound indirectly inhibits POC5 by interrupting its role in centriole maturation. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
An Aurora kinase inhibitor that affects spindle assembly and chromosome alignment, processes in which POC5 is involved for proper centriole function. Inhibition of Aurora kinase can indirectly inhibit POC5 activity by disrupting its role in these processes. | ||||||
S-Trityl-L-cysteine | 2799-07-7 | sc-202799 sc-202799A | 1 g 5 g | $32.00 $66.00 | 6 | |
A specific Eg5 kinesin inhibitor that disrupts the formation of the bipolar spindle, indirectly inhibiting POC5's role in centriole duplication and spindle pole integrity. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $153.00 $938.00 | 5 | |
A receptor tyrosine kinase inhibitor that could indirectly inhibit POC5 by affecting signal transduction pathways involved in cell cycle regulation and centriole function. | ||||||
Dinaciclib | 779353-01-4 | sc-364483 sc-364483A | 5 mg 25 mg | $247.00 $888.00 | 1 | |
A CDK inhibitor that impairs cell cycle progression and could indirectly inhibit POC5 by disrupting centriole duplication, where POC5 is directly involved. | ||||||